Atlas Trials

Henlix, Inc

5 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Henlix, Inc

RecordFirmDate
Evaluate Safety, Tolerability and PK of HLX55 in Patients With Advanced Solid Tumors With Different cMET Status (NCT04169178)Henlix, Inc2020-03-03
Evaluate the Efficacy and Safety of HLX10 in Chronic Hepatitis B Patients (NCT04133259)Henlix, Inc2019-12-31
A Study of HLX06, a Humanized Monoclonal Antibody Targeting Human Vascular Endothelial Growth Factor Receptor-2 in Patients With Advanced Solid Tumors (NCT03494231)Henlix, Inc2018-03-22
Phase 1 Study of HLX10, a Monoclonal Antibody Targeting Programmed Death-1 (PD-1) in Patients With Advanced Solid Tumors (NCT03468751)Henlix, Inc2018-02-14

Track Henlix, Inc automatically

Every clearance here is in the API, with alerts when new ones post.